Question 1

How many shares of RARE does Candriam S.C.A. own?

Accepted Answer

As of 2026-Q2, Candriam S.C.A. holds 1M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN).

Question 2

What is Candriam S.C.A.'s RARE position worth?

Accepted Answer

As of 2026-Q2, Candriam S.C.A.'s RARE position is worth $33.4M.

Question 3

Is Candriam S.C.A. buying or selling RARE?

Accepted Answer

In 2026-Q2, Candriam S.C.A. decreased their RARE position (-8.6% change in shares).

Question 4

When did Candriam S.C.A. first buy RARE?

Accepted Answer

Based on available 13F filings, Candriam S.C.A. first reported a position in RARE in 2024-Q3. They have held the position across 29 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1M	-8.6%	$33.4M	0.2%	$33.39	0
2026-Q1	Increased	1.1M	+37.1%	$23M	0.1%	$22.07	45
2025-Q4	Increased	799,384	+5.9%	$18.4M	0.1%	$22.78	30
2025-Q3	Increased	754,714	+43.4%	$22.7M	0.1%	$30.36	46
2025-Q2	Decreased	526,267	-27.7%	$19.1M	0.1%	$36.52	0
2025-Q1	Increased	728,017	+8.0%	$26.4M	0.2%	$37.82	37
2024-Q4	Decreased	674,257	-5.5%	$28.4M	0.2%	$42.27	0
2024-Q3	Increased	713,092	+3.5%	$39.6M	0.2%	$54.43	36

RAREShowing 8 of 29 quarters

RARE
Showing 8 of 29 quarters